Lupin said that its board has approved to carve out trade generics business in India to its wholly owned subsidiary, Lupin Life Sciences (LLSL) on a slump sale basis.
Subscribe To Our Free Newsletter |
Lupin said that its board has approved to carve out trade generics business in India to its wholly owned subsidiary, Lupin Life Sciences (LLSL) on a slump sale basis.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!